CG MedTech, Liv Science Partner on CDMO for Allogeneic Dermis Products
"Collaboration on the Production and Supply of Human Tissue Products"
CG MedTech said on October 27 that it will collaborate with Liv Science, an integrated medical aesthetics platform company, on contract development and manufacturing (CDMO) of human tissue products based on allogeneic dermis.
The collaboration aims to establish a reliable foundation for the production and supply of products by combining CG MedTech’s human tissue manufacturing and quality management capabilities with Liv Science’s expertise in the medical aesthetics business. CG MedTech will handle product manufacturing and quality management, while Liv Science will work to commercialize the products and expand their market presence as the companies continue their partnership.
CG MedTech CEO Yoo Hyunseung (right) and LIV Science CEO Han Jonghyun pose for a commemorative photo at the ECM brand launch agreement ceremony. CG MedTech
View original imageThe collaboration covers human tissue products that leverage the extracellular matrix (ECM) properties of allogeneic dermis. CG MedTech plans to reliably manufacture and supply products that meet its partners’ requirements, drawing on its manufacturing system spanning raw material management, processing and production, quality management, and supply.
CG MedTech plans to expand its collaborations with various partners and foster its human tissue CDMO business as a foundation for mid- to long-term growth.
“In the human tissue CDMO business, it is important to build trust by reliably supplying products that meet partners’ quality requirements on the agreed schedule,” said Yoo Hyunseung, CEO of CG MedTech. “Building on Regen Hub’s manufacturing and quality management capabilities, we will establish long-term supply relationships with clients and increase production capacity in line with growing demand.”
Hot Picks Today
"Koreans Spend 1 Million Won Each and Come Back"... 'They Said They Were Going for Value for Money,' but Open Their Wallets Wide in Japan- "You Mean Only Older Men Got to Enjoy This?"... Women in Their 20s and 30s Find Comfort Sipping Drinks at Standing Bars
- After Monthly Rents Hit KRW 8 Million, 'Housing Emergency' Declared... AI Boom Draws Wealthy to 'This City'
- "Naked Again?" Controversial Actress Crosses a Line... Slammed for Sexualizing 'Child Characters'
- "They Get a Good Night's Sleep and Earn Twice My Salary... Honestly, I'm So Jealous I Could Die": Civil Servant's Post Targeting Firefighters Sparks Outrage
“We will continue to provide customers with the best value based on our advanced medical aesthetics portfolio and further strengthen our position in the market,” said Han Jonghyun, CEO of Liv Science.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
